Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2023-04-05 00:00:00 ET · period of report 2023-04-03 · accession 0001209191-23-023402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-05 | 2023-04-03 | TYRA | Harris Todd | CEO, Dir | S - Sale+OE | $16.13 | -2,000 | 1.70M | -0.1% | -$32.3K |
| D | 2023-04-05 | 2023-04-03 | TYRA | Harris Todd | CEO, Dir | M - OptEx | $2.25 | +2,000 | 1.70M | +0.1% | +$4,500 |
| D | 2023-04-05 | 2023-04-03 | TYRA | Harris Todd | CEO, Dir | M - OptEx | $0.00 | -2,000 | 397.5K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | S | D | 2,000 | $16.13 | 1,701,276 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 and $16.240. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
| 2 | Common | Common Stock | 2023-04-03 | M | A | 2,000 | $2.25 | 1,703,276 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-03 | M | D | 2,000 | $0.00 | 397,537 | D | $2.25 · — to 2031-03-09 | 2,000 Common Stock | (F3) 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. |